F.D.A. Approves the Drug Daraxonrasib That’s Poised to Transform Pancreatic Cancer
Global - North America
Archived
•
August 26, 2026
•
In a key clinical trial, patients who got the pill, daraxonrasib, lived twice as long as those who got chemotherapy.
Source: NYT Home Page | https://rss.nytimes.com/services/xml/rss/nyt/HomePage.xml - Read Original
"What you put in is not always what you get out."
Discussion (0)
Please log in to post a comment.
No comments yet. Be the first to share your thoughts!
Sponsored
"Cardamom Spices and more to satisfy the tastebuds 100g $14.94"
"Adventure is where you chose to go."